Trials / Terminated
TerminatedNCT04193878
ARrest RESpiraTory Failure From PNEUMONIA
ARrest RESpiraTory Failure From PNEUMONIA (ARREST PNEUMONIA)
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 465 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study seeks to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inhaled budesonide and formoterol | aerosolized doses of budesonide (1.0 mg/2 ml) and formoterol (20 mg/2 ml) twice daily for up to 5 days |
| DRUG | Inhaled placebo | aerosolized saline (4 ml of 0.9% saline) twice daily for up to 5 days |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2025-07-22
- Completion
- 2025-07-22
- First posted
- 2019-12-10
- Last updated
- 2025-08-19
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04193878. Inclusion in this directory is not an endorsement.